We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Grifols Accused Of Off-Label Drug Uses In FCA Suit

Law360, New York (December 8, 2016, 8:41 PM EST) -- Spanish pharmaceutical company Grifols SA potentially bilked the federal government, 28 states and Washington, D.C., out of millions of dollars by inappropriately marketing unapproved uses of a drug for a rare...
To view the full article, register now.




Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only


Florida Middle

Nature of Suit

Qui Tam (31 U.S.C. ยง 3729(a))


Subscribers Only

Date Filed

January 28, 2016


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.